Asterasys

450950 · KOSDAQ · ₩450950 · 아스테라시스

₩4,895▼ ₩155 (3.07%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −67.54%
Market cap
₩184B
Enterprise value
₩181B
P/E
24.3×
P/B
4.1×
Dividend yield
2.1%
ROE
16.7%
Net margin
19.1%

Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−71.6% from the high

₩4,050Today: ₩4,870 – ₩5,100₩17,240

Returns

  • 1W−6.9%
  • 1M−6.2%
  • 3M−12.0%
  • 6M−57.4%
  • YTD−60.4%
  • 1Y−67.5%
Volume today
25,874
0.4× the 20-day average
Traded today
₩128M
Listed shares
37,627,592
EPS (12 months)
₩201
Earnings yield 4.1%
AI researchResearch being writtenOur AI is writing a report on this company from filed data, prices and news. Check back soon.

Upcoming dates

Full calendar →

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

Signals

30Quiet
  • BuzzQuietBuzz 30 of 100 (50 is a normal day for this stock).
  • MomentumWeak-5.7% over the last month; the price is below its 20-day average.

Signals describe activity, not recommendations. Not financial advice.

Asterasys stock overview

Asterasys (아스테라시스, KRX: 450950) is listed on KOSDAQ, in the Medical & precision devices sector. The company manufactures and sells aesthetic medical devices, focused on anti-aging, including HIFU (high-intensity focused ultrasound) and non-invasive radiofrequency (RF) skin treatment devices. Its shares closed at ₩4,895 on Oct 27, 2026, down 3.07% on the day, giving it a market value of ₩184B.

Key facts

Market cap
₩184B
Sector
Medical & precision devices
Latest price change
−3.07%
As of
Oct 27, 2026
Main business
The company manufactures and sells aesthetic medical devices, focused on anti-aging, including HIFU (high-intensity focused ultrasound) and non-invasive radiofrequency (RF) skin treatment devices.

Quick answers about Asterasys

What does Asterasys do?
The company manufactures and sells aesthetic medical devices, focused on anti-aging, including HIFU (high-intensity focused ultrasound) and non-invasive radiofrequency (RF) skin treatment devices. Its main products are the Liftera HIFU device, the Coolfase RF device, the Coolsoniq HIFU device, and consumables such as cartridges and tips, sold to clinics in Korea and overseas through direct sales and distributors. S.
What is the market cap of Asterasys?
The market capitalisation of Asterasys was ₩184B at the close on Oct 27, 2026.
Who are the largest shareholders of Asterasys?
According to the latest official filings, the largest reported holders are Seo Eun-taek (45.87%, as of Sep 29, 2026); Kim Jong-seok (6.42%, as of Feb 12, 2026); Lee In-ho (3.89%, as of Aug 5, 2025).
When is the next earnings report from Asterasys?
Korean companies rarely announce results dates in advance. Based on when Asterasys filed the same report in past years, its next 3q results is expected around Nov 13, 2026.
Does the National Pension Service own Asterasys?
Yes. The National Pension Service held 0.41% of Asterasys shares as of Dec 31, 2025.

Company profile

The company manufactures and sells aesthetic medical devices, focused on anti-aging, including HIFU (high-intensity focused ultrasound) and non-invasive radiofrequency (RF) skin treatment devices. Its main products are the Liftera HIFU device, the Coolfase RF device, the Coolsoniq HIFU device, and consumables such as cartridges and tips, sold to clinics in Korea and overseas through direct sales and distributors. The company operates in South Korea and sells internationally, with plans to pursue U.S. FDA certification for new devices to enter North America.

Written by AI from the company's latest annual report.

Korean name
아스테라시스
CEO
서은택
Founded
Jul 2015
Listed
Jan 2025
Listed shares
37,627,592
Fiscal year ends
Month 12

Similar companies

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: Asterasys / 아스테라시스 / 450950 / KRX:450950

Source: KRX statistical information